Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1334, 2011-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
US FDA reviews safety of Stalevo
Reactions Weekly, Vol. 1, Iss. 1297, 2010-01 ,pp. :
Access to resources
Recommend
GnRH agonists: US FDA reviews CV safety
Reactions Weekly, Vol. 1, Iss. 1300, 2010-01 ,pp. :
FDA is reviewing safety of omalizumab
Reactions Weekly, Vol. 1, Iss. 1262, 2009-01 ,pp. :
Patient safety not on FDA's agenda
Inpharma, Vol. 1, Iss. 1605, 2007-01 ,pp. :
US FDA reviewing safety of orlistat
Reactions Weekly, Vol. 1, Iss. 1267, 2009-01 ,pp. :